摘要
目的探讨依曲替酸对中、重度银屑病患者皮损区白介素(IL)-17表达的影响。方法观察依曲替酸的临床疗效;用原位杂交技术及蛋白印迹法(Westernblot)检测患者治疗前、后皮损区IL-17mRNA和IL-17蛋白表达。结果依曲替酸在改善患者病情的同时,抑制了皮损区IL-17mRNA的表达(治疗前39.95±11.44,治疗后16.20±6.65)及蛋白表达(治疗前0.85±0.10,治疗后0.26±0.10),差异均有统计学意义(P均<0.05)。结论依曲替酸治疗银屑病的作用可能涉及对患者皮肤Th17细胞的影响。
Objective To investigate the effect of acitretin on expression of lnterleukin (IL)-17 in lesions of psoriatic patients. Methods The clinical effects of acitretin on psoriatic patients were observed. The mRNA and protein of IL-17 in lesions before and after the treatment were measured by hybridization in situ and western blot. Results The patient's condition improved greatly after aeitretin treatment. The level of IL-17mRNA ( prior treatment 39.95 ± 11.44,post-treatment 16.20±6.65 ) and IL-17 protein ( prior treatment 0.85± 0.10,post-treatment 0.26 ± 0.10) ( all P 〈 0.05) decreased significantly. Conclusion Thl7 cells may be involved in the effect of aeitretin in treating psoriatic patients.
出处
《中国皮肤性病学杂志》
CAS
北大核心
2010年第7期613-615,共3页
The Chinese Journal of Dermatovenereology
基金
教育部博士点基金新教师项目(编号:20070698071)
陕西省科学技术研究发展计划项目(编号:2008K15-06(14))